| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T2908 |
0-7 |
JJ |
denotes |
Organic |
| T2909 |
8-12 |
NN |
denotes |
Acid |
| T2910 |
13-16 |
CC |
denotes |
and |
| T2911 |
17-30 |
NN |
denotes |
Acylcarnitine |
| T2912 |
31-39 |
NN |
denotes |
Analysis |
| T2913 |
39-170 |
sentence |
denotes |
Urine organic acid analysis revealed that MCAD−/− mice developed an organic acid profile similar to MCAD-deficient human patients. |
| T2914 |
40-45 |
NN |
denotes |
Urine |
| T2916 |
46-53 |
JJ |
denotes |
organic |
| T2915 |
54-58 |
NN |
denotes |
acid |
| T2917 |
59-67 |
NN |
denotes |
analysis |
| T2918 |
68-76 |
VBD |
denotes |
revealed |
| T2919 |
77-81 |
IN |
denotes |
that |
| T2921 |
82-86 |
NN |
denotes |
MCAD |
| T2923 |
86-87 |
SYM |
denotes |
− |
| T2924 |
87-88 |
HYPH |
denotes |
/ |
| T2925 |
88-89 |
SYM |
denotes |
− |
| T2922 |
90-94 |
NNS |
denotes |
mice |
| T2920 |
95-104 |
VBD |
denotes |
developed |
| T2926 |
105-107 |
DT |
denotes |
an |
| T2928 |
108-115 |
JJ |
denotes |
organic |
| T2929 |
116-120 |
NN |
denotes |
acid |
| T2927 |
121-128 |
NN |
denotes |
profile |
| T2930 |
129-136 |
JJ |
denotes |
similar |
| T2931 |
137-139 |
IN |
denotes |
to |
| T2932 |
140-144 |
NN |
denotes |
MCAD |
| T2934 |
144-145 |
HYPH |
denotes |
- |
| T2933 |
145-154 |
JJ |
denotes |
deficient |
| T2936 |
155-160 |
JJ |
denotes |
human |
| T2935 |
161-169 |
NNS |
denotes |
patients |
| T2937 |
169-170 |
. |
denotes |
. |
| T2938 |
170-439 |
sentence |
denotes |
Specifically, when fasted for 18 h, MCAD−/− mice developed significantly elevated concentrations of adipic, suberic, and sebacic acids and hexanoylglycine as compared to MCAD+/+ controls, which showed trace to no detectable amounts of the same organic acids (Table 1). |
| T2939 |
171-183 |
RB |
denotes |
Specifically |
| T2941 |
183-185 |
, |
denotes |
, |
| T2942 |
185-189 |
WRB |
denotes |
when |
| T2943 |
190-196 |
VBN |
denotes |
fasted |
| T2944 |
197-200 |
IN |
denotes |
for |
| T2945 |
201-203 |
CD |
denotes |
18 |
| T2946 |
204-205 |
NN |
denotes |
h |
| T2947 |
205-207 |
, |
denotes |
, |
| T2948 |
207-211 |
NN |
denotes |
MCAD |
| T2950 |
211-212 |
SYM |
denotes |
− |
| T2951 |
212-213 |
HYPH |
denotes |
/ |
| T2952 |
213-214 |
SYM |
denotes |
− |
| T2949 |
215-219 |
NNS |
denotes |
mice |
| T2940 |
220-229 |
VBD |
denotes |
developed |
| T2953 |
230-243 |
RB |
denotes |
significantly |
| T2954 |
244-252 |
VBN |
denotes |
elevated |
| T2955 |
253-267 |
NNS |
denotes |
concentrations |
| T2956 |
268-270 |
IN |
denotes |
of |
| T2957 |
271-277 |
JJ |
denotes |
adipic |
| T2959 |
277-279 |
, |
denotes |
, |
| T2960 |
279-286 |
JJ |
denotes |
suberic |
| T2961 |
286-288 |
, |
denotes |
, |
| T2962 |
288-291 |
CC |
denotes |
and |
| T2963 |
292-299 |
JJ |
denotes |
sebacic |
| T2958 |
300-305 |
NNS |
denotes |
acids |
| T2964 |
306-309 |
CC |
denotes |
and |
| T2965 |
310-325 |
NN |
denotes |
hexanoylglycine |
| T2966 |
326-328 |
IN |
denotes |
as |
| T2967 |
329-337 |
VBN |
denotes |
compared |
| T2968 |
338-340 |
IN |
denotes |
to |
| T2969 |
341-345 |
NN |
denotes |
MCAD |
| T2971 |
345-346 |
SYM |
denotes |
+ |
| T2972 |
346-347 |
HYPH |
denotes |
/ |
| T2973 |
347-348 |
SYM |
denotes |
+ |
| T2970 |
349-357 |
NNS |
denotes |
controls |
| T2974 |
357-359 |
, |
denotes |
, |
| T2975 |
359-364 |
WDT |
denotes |
which |
| T2976 |
365-371 |
VBD |
denotes |
showed |
| T2977 |
372-377 |
NN |
denotes |
trace |
| T2978 |
378-380 |
IN |
denotes |
to |
| T2979 |
381-383 |
DT |
denotes |
no |
| T2981 |
384-394 |
JJ |
denotes |
detectable |
| T2980 |
395-402 |
NNS |
denotes |
amounts |
| T2982 |
403-405 |
IN |
denotes |
of |
| T2983 |
406-409 |
DT |
denotes |
the |
| T2985 |
410-414 |
JJ |
denotes |
same |
| T2986 |
415-422 |
JJ |
denotes |
organic |
| T2984 |
423-428 |
NNS |
denotes |
acids |
| T2987 |
429-430 |
-LRB- |
denotes |
( |
| T2988 |
430-435 |
NN |
denotes |
Table |
| T2989 |
436-437 |
CD |
denotes |
1 |
| T2990 |
437-438 |
-RRB- |
denotes |
) |
| T2991 |
438-439 |
. |
denotes |
. |
| T2992 |
439-487 |
sentence |
denotes |
Adipic acid is not specific to MCAD deficiency. |
| T2993 |
440-446 |
JJ |
denotes |
Adipic |
| T2994 |
447-451 |
NN |
denotes |
acid |
| T2995 |
452-454 |
VBZ |
denotes |
is |
| T2996 |
455-458 |
RB |
denotes |
not |
| T2997 |
459-467 |
JJ |
denotes |
specific |
| T2998 |
468-470 |
IN |
denotes |
to |
| T2999 |
471-475 |
NN |
denotes |
MCAD |
| T3000 |
476-486 |
NN |
denotes |
deficiency |
| T3001 |
486-487 |
. |
denotes |
. |
| T3002 |
487-631 |
sentence |
denotes |
We also evaluated β-hydroxybutyric and acetoacetic concentrations and found no significant differences between MCAD genotypes (data not shown). |
| T3003 |
488-490 |
PRP |
denotes |
We |
| T3005 |
491-495 |
RB |
denotes |
also |
| T3004 |
496-505 |
VBD |
denotes |
evaluated |
| T3006 |
506-507 |
NN |
denotes |
β |
| T3008 |
507-508 |
HYPH |
denotes |
- |
| T3007 |
508-522 |
JJ |
denotes |
hydroxybutyric |
| T3010 |
523-526 |
CC |
denotes |
and |
| T3011 |
527-538 |
JJ |
denotes |
acetoacetic |
| T3009 |
539-553 |
NNS |
denotes |
concentrations |
| T3012 |
554-557 |
CC |
denotes |
and |
| T3013 |
558-563 |
VBD |
denotes |
found |
| T3014 |
564-566 |
DT |
denotes |
no |
| T3016 |
567-578 |
JJ |
denotes |
significant |
| T3015 |
579-590 |
NNS |
denotes |
differences |
| T3017 |
591-598 |
IN |
denotes |
between |
| T3018 |
599-603 |
NN |
denotes |
MCAD |
| T3019 |
604-613 |
NNS |
denotes |
genotypes |
| T3020 |
614-615 |
-LRB- |
denotes |
( |
| T3022 |
615-619 |
NNS |
denotes |
data |
| T3023 |
620-623 |
RB |
denotes |
not |
| T3021 |
624-629 |
VBN |
denotes |
shown |
| T3024 |
629-630 |
-RRB- |
denotes |
) |
| T3025 |
630-631 |
. |
denotes |
. |
| T3026 |
631-903 |
sentence |
denotes |
Comparison of MCAD+/+ and MCAD−/− mice revealed no significant differences in total serum carnitine concentrations between MCAD+/+ and MCAD−/− mice, but MCAD−/− mice had a 5- to 6-fold elevation of serum decenoylcarnitine evident in the acylcarnitine profile (Figure 4A). |
| T3027 |
632-642 |
NN |
denotes |
Comparison |
| T3029 |
643-645 |
IN |
denotes |
of |
| T3030 |
646-650 |
NN |
denotes |
MCAD |
| T3032 |
650-651 |
SYM |
denotes |
+ |
| T3033 |
651-652 |
HYPH |
denotes |
/ |
| T3034 |
652-653 |
SYM |
denotes |
+ |
| T3035 |
654-657 |
CC |
denotes |
and |
| T3036 |
658-662 |
NN |
denotes |
MCAD |
| T3037 |
662-663 |
SYM |
denotes |
− |
| T3038 |
663-664 |
HYPH |
denotes |
/ |
| T3039 |
664-665 |
SYM |
denotes |
− |
| T3031 |
666-670 |
NNS |
denotes |
mice |
| T3028 |
671-679 |
VBD |
denotes |
revealed |
| T3040 |
680-682 |
DT |
denotes |
no |
| T3042 |
683-694 |
JJ |
denotes |
significant |
| T3041 |
695-706 |
NNS |
denotes |
differences |
| T3043 |
707-709 |
IN |
denotes |
in |
| T3044 |
710-715 |
JJ |
denotes |
total |
| T3046 |
716-721 |
NN |
denotes |
serum |
| T3047 |
722-731 |
NN |
denotes |
carnitine |
| T3045 |
732-746 |
NNS |
denotes |
concentrations |
| T3048 |
747-754 |
IN |
denotes |
between |
| T3049 |
755-759 |
NN |
denotes |
MCAD |
| T3051 |
759-760 |
SYM |
denotes |
+ |
| T3052 |
760-761 |
HYPH |
denotes |
/ |
| T3053 |
761-762 |
SYM |
denotes |
+ |
| T3054 |
763-766 |
CC |
denotes |
and |
| T3055 |
767-771 |
NN |
denotes |
MCAD |
| T3056 |
771-772 |
SYM |
denotes |
− |
| T3057 |
772-773 |
HYPH |
denotes |
/ |
| T3058 |
773-774 |
SYM |
denotes |
− |
| T3050 |
775-779 |
NNS |
denotes |
mice |
| T3059 |
779-781 |
, |
denotes |
, |
| T3060 |
781-784 |
CC |
denotes |
but |
| T3061 |
785-789 |
NN |
denotes |
MCAD |
| T3063 |
789-790 |
SYM |
denotes |
− |
| T3064 |
790-791 |
HYPH |
denotes |
/ |
| T3065 |
791-792 |
SYM |
denotes |
− |
| T3062 |
793-797 |
NNS |
denotes |
mice |
| T3066 |
798-801 |
VBD |
denotes |
had |
| T3067 |
802-803 |
DT |
denotes |
a |
| T3069 |
804-805 |
CD |
denotes |
5 |
| T3071 |
805-806 |
HYPH |
denotes |
- |
| T3072 |
807-809 |
IN |
denotes |
to |
| T3070 |
810-811 |
CD |
denotes |
6 |
| T3074 |
811-812 |
HYPH |
denotes |
- |
| T3073 |
812-816 |
JJ |
denotes |
fold |
| T3068 |
817-826 |
NN |
denotes |
elevation |
| T3076 |
827-829 |
IN |
denotes |
of |
| T3077 |
830-835 |
NN |
denotes |
serum |
| T3078 |
836-853 |
NN |
denotes |
decenoylcarnitine |
| T3075 |
854-861 |
JJ |
denotes |
evident |
| T3079 |
862-864 |
IN |
denotes |
in |
| T3080 |
865-868 |
DT |
denotes |
the |
| T3082 |
869-882 |
NN |
denotes |
acylcarnitine |
| T3081 |
883-890 |
NN |
denotes |
profile |
| T3083 |
891-892 |
-LRB- |
denotes |
( |
| T3084 |
892-898 |
NN |
denotes |
Figure |
| T3085 |
899-901 |
CD |
denotes |
4A |
| T3086 |
901-902 |
-RRB- |
denotes |
) |
| T3087 |
902-903 |
. |
denotes |
. |
| T3088 |
903-997 |
sentence |
denotes |
Bile acylcarnitine analysis revealed a similar acylcarnitine pattern as in serum (Figure 4B). |
| T3089 |
904-908 |
NN |
denotes |
Bile |
| T3090 |
909-922 |
NN |
denotes |
acylcarnitine |
| T3091 |
923-931 |
NN |
denotes |
analysis |
| T3092 |
932-940 |
VBD |
denotes |
revealed |
| T3093 |
941-942 |
DT |
denotes |
a |
| T3095 |
943-950 |
JJ |
denotes |
similar |
| T3096 |
951-964 |
NN |
denotes |
acylcarnitine |
| T3094 |
965-972 |
NN |
denotes |
pattern |
| T3097 |
973-975 |
IN |
denotes |
as |
| T3098 |
976-978 |
IN |
denotes |
in |
| T3099 |
979-984 |
NN |
denotes |
serum |
| T3100 |
985-986 |
-LRB- |
denotes |
( |
| T3101 |
986-992 |
NN |
denotes |
Figure |
| T3102 |
993-995 |
CD |
denotes |
4B |
| T3103 |
995-996 |
-RRB- |
denotes |
) |
| T3104 |
996-997 |
. |
denotes |
. |
| T3105 |
997-1124 |
sentence |
denotes |
However, the acylcarnitine profiles of the MCAD−/− mice are different from those of human MCAD-deficient patients (Figure 4C). |
| T3106 |
998-1005 |
RB |
denotes |
However |
| T3108 |
1005-1007 |
, |
denotes |
, |
| T3109 |
1007-1010 |
DT |
denotes |
the |
| T3111 |
1011-1024 |
NN |
denotes |
acylcarnitine |
| T3110 |
1025-1033 |
NNS |
denotes |
profiles |
| T3112 |
1034-1036 |
IN |
denotes |
of |
| T3113 |
1037-1040 |
DT |
denotes |
the |
| T3115 |
1041-1045 |
NN |
denotes |
MCAD |
| T3116 |
1045-1046 |
SYM |
denotes |
− |
| T3117 |
1046-1047 |
HYPH |
denotes |
/ |
| T3118 |
1047-1048 |
SYM |
denotes |
− |
| T3114 |
1049-1053 |
NNS |
denotes |
mice |
| T3107 |
1054-1057 |
VBP |
denotes |
are |
| T3119 |
1058-1067 |
JJ |
denotes |
different |
| T3120 |
1068-1072 |
IN |
denotes |
from |
| T3121 |
1073-1078 |
DT |
denotes |
those |
| T3122 |
1079-1081 |
IN |
denotes |
of |
| T3123 |
1082-1087 |
JJ |
denotes |
human |
| T3125 |
1088-1092 |
NN |
denotes |
MCAD |
| T3127 |
1092-1093 |
HYPH |
denotes |
- |
| T3126 |
1093-1102 |
JJ |
denotes |
deficient |
| T3124 |
1103-1111 |
NNS |
denotes |
patients |
| T3128 |
1112-1113 |
-LRB- |
denotes |
( |
| T3129 |
1113-1119 |
NN |
denotes |
Figure |
| T3130 |
1120-1122 |
CD |
denotes |
4C |
| T3131 |
1122-1123 |
-RRB- |
denotes |
) |
| T3132 |
1123-1124 |
. |
denotes |
. |
| T3133 |
1124-1340 |
sentence |
denotes |
Human patients present with elevated levels of C6, C8, and C10:1 acylcarnitines, as did the mutant mice; however, the predominant peak was C8 acylcarnitine in humans, whereas in the mouse it was C10:1 acylcarnitine. |
| T3134 |
1125-1130 |
JJ |
denotes |
Human |
| T3135 |
1131-1139 |
NNS |
denotes |
patients |
| T3136 |
1140-1147 |
VBP |
denotes |
present |
| T3138 |
1148-1152 |
IN |
denotes |
with |
| T3139 |
1153-1161 |
VBN |
denotes |
elevated |
| T3140 |
1162-1168 |
NNS |
denotes |
levels |
| T3141 |
1169-1171 |
IN |
denotes |
of |
| T3142 |
1172-1174 |
NN |
denotes |
C6 |
| T3143 |
1174-1176 |
, |
denotes |
, |
| T3144 |
1176-1178 |
NN |
denotes |
C8 |
| T3145 |
1178-1180 |
, |
denotes |
, |
| T3146 |
1180-1183 |
CC |
denotes |
and |
| T3147 |
1184-1187 |
NN |
denotes |
C10 |
| T3148 |
1187-1188 |
: |
denotes |
: |
| T3149 |
1188-1189 |
CD |
denotes |
1 |
| T3150 |
1190-1204 |
NNS |
denotes |
acylcarnitines |
| T3151 |
1204-1206 |
, |
denotes |
, |
| T3152 |
1206-1208 |
IN |
denotes |
as |
| T3153 |
1209-1212 |
VBD |
denotes |
did |
| T3154 |
1213-1216 |
DT |
denotes |
the |
| T3156 |
1217-1223 |
NN |
denotes |
mutant |
| T3155 |
1224-1228 |
NNS |
denotes |
mice |
| T3157 |
1228-1229 |
: |
denotes |
; |
| T3158 |
1230-1237 |
RB |
denotes |
however |
| T3159 |
1237-1239 |
, |
denotes |
, |
| T3160 |
1239-1242 |
DT |
denotes |
the |
| T3162 |
1243-1254 |
JJ |
denotes |
predominant |
| T3161 |
1255-1259 |
NN |
denotes |
peak |
| T3137 |
1260-1263 |
VBD |
denotes |
was |
| T3163 |
1264-1266 |
NN |
denotes |
C8 |
| T3164 |
1267-1280 |
NN |
denotes |
acylcarnitine |
| T3165 |
1281-1283 |
IN |
denotes |
in |
| T3166 |
1284-1290 |
NNS |
denotes |
humans |
| T3167 |
1290-1292 |
, |
denotes |
, |
| T3168 |
1292-1299 |
IN |
denotes |
whereas |
| T3170 |
1300-1302 |
IN |
denotes |
in |
| T3171 |
1303-1306 |
DT |
denotes |
the |
| T3172 |
1307-1312 |
NN |
denotes |
mouse |
| T3173 |
1313-1315 |
PRP |
denotes |
it |
| T3169 |
1316-1319 |
VBD |
denotes |
was |
| T3174 |
1320-1323 |
NN |
denotes |
C10 |
| T3176 |
1323-1324 |
: |
denotes |
: |
| T3177 |
1324-1325 |
CD |
denotes |
1 |
| T3175 |
1326-1339 |
NN |
denotes |
acylcarnitine |
| T3178 |
1339-1340 |
. |
denotes |
. |
| T7814 |
1351-1364 |
NN |
denotes |
Acylcarnitine |
| T7815 |
1365-1373 |
NNS |
denotes |
Analyses |
| T7816 |
1373-1450 |
sentence |
denotes |
(A) Serum acylcarnitine analysis of MCAD+/+ (n = 4) and MCAD−/− mice (n = 4) |
| T7817 |
1374-1375 |
-LRB- |
denotes |
( |
| T7818 |
1375-1376 |
LS |
denotes |
A |
| T7820 |
1376-1377 |
-RRB- |
denotes |
) |
| T7821 |
1378-1383 |
NN |
denotes |
Serum |
| T7822 |
1384-1397 |
NN |
denotes |
acylcarnitine |
| T7819 |
1398-1406 |
NN |
denotes |
analysis |
| T7823 |
1407-1409 |
IN |
denotes |
of |
| T7824 |
1410-1414 |
NN |
denotes |
MCAD |
| T7826 |
1414-1415 |
SYM |
denotes |
+ |
| T7827 |
1415-1416 |
HYPH |
denotes |
/ |
| T7828 |
1416-1417 |
SYM |
denotes |
+ |
| T7829 |
1418-1419 |
-LRB- |
denotes |
( |
| T7831 |
1419-1420 |
NN |
denotes |
n |
| T7832 |
1421-1422 |
SYM |
denotes |
= |
| T7830 |
1423-1424 |
CD |
denotes |
4 |
| T7833 |
1424-1425 |
-RRB- |
denotes |
) |
| T7834 |
1426-1429 |
CC |
denotes |
and |
| T7835 |
1430-1434 |
NN |
denotes |
MCAD |
| T7836 |
1434-1435 |
SYM |
denotes |
− |
| T7837 |
1435-1436 |
HYPH |
denotes |
/ |
| T7838 |
1436-1437 |
SYM |
denotes |
− |
| T7825 |
1438-1442 |
NNS |
denotes |
mice |
| T7839 |
1443-1444 |
-LRB- |
denotes |
( |
| T7841 |
1444-1445 |
NN |
denotes |
n |
| T7842 |
1446-1447 |
SYM |
denotes |
= |
| T7840 |
1448-1449 |
CD |
denotes |
4 |
| T7843 |
1449-1450 |
-RRB- |
denotes |
) |
| T7844 |
1450-1538 |
sentence |
denotes |
There are significant elevations in acylcarnitine species as indicated in MCAD−/− mice. |
| T7845 |
1451-1456 |
EX |
denotes |
There |
| T7846 |
1457-1460 |
VBP |
denotes |
are |
| T7847 |
1461-1472 |
JJ |
denotes |
significant |
| T7848 |
1473-1483 |
NNS |
denotes |
elevations |
| T7849 |
1484-1486 |
IN |
denotes |
in |
| T7850 |
1487-1500 |
NN |
denotes |
acylcarnitine |
| T7851 |
1501-1508 |
NNS |
denotes |
species |
| T7852 |
1509-1511 |
IN |
denotes |
as |
| T7853 |
1512-1521 |
VBN |
denotes |
indicated |
| T7854 |
1522-1524 |
IN |
denotes |
in |
| T7855 |
1525-1529 |
NN |
denotes |
MCAD |
| T7857 |
1529-1530 |
SYM |
denotes |
− |
| T7858 |
1530-1531 |
HYPH |
denotes |
/ |
| T7859 |
1531-1532 |
SYM |
denotes |
− |
| T7856 |
1533-1537 |
NNS |
denotes |
mice |
| T7860 |
1537-1538 |
. |
denotes |
. |
| T7861 |
1538-1594 |
sentence |
denotes |
Values shown are mean values ± standard deviation (SD). |
| T7862 |
1539-1545 |
NNS |
denotes |
Values |
| T7864 |
1546-1551 |
VBN |
denotes |
shown |
| T7863 |
1552-1555 |
VBP |
denotes |
are |
| T7865 |
1556-1560 |
NN |
denotes |
mean |
| T7866 |
1561-1567 |
NNS |
denotes |
values |
| T7867 |
1568-1569 |
SYM |
denotes |
± |
| T7868 |
1570-1578 |
JJ |
denotes |
standard |
| T7869 |
1579-1588 |
NN |
denotes |
deviation |
| T7870 |
1589-1590 |
-LRB- |
denotes |
( |
| T7871 |
1590-1592 |
NN |
denotes |
SD |
| T7872 |
1592-1593 |
-RRB- |
denotes |
) |
| T7873 |
1593-1594 |
. |
denotes |
. |
| T7874 |
1594-1649 |
sentence |
denotes |
Asterisk indicates p < 0.002 and ‡ indicates p < 0.01. |
| T7875 |
1595-1603 |
NN |
denotes |
Asterisk |
| T7876 |
1604-1613 |
VBZ |
denotes |
indicates |
| T7877 |
1614-1615 |
NN |
denotes |
p |
| T7878 |
1616-1617 |
SYM |
denotes |
< |
| T7879 |
1618-1623 |
CD |
denotes |
0.002 |
| T7880 |
1624-1627 |
CC |
denotes |
and |
| T7881 |
1628-1629 |
SYM |
denotes |
‡ |
| T7882 |
1630-1639 |
VBZ |
denotes |
indicates |
| T7883 |
1640-1641 |
NN |
denotes |
p |
| T7884 |
1642-1643 |
SYM |
denotes |
< |
| T7885 |
1644-1648 |
CD |
denotes |
0.01 |
| T7886 |
1648-1649 |
. |
denotes |
. |
| T7887 |
1649-1753 |
sentence |
denotes |
(B) There are significant elevations in bile acylcarnitines of the same mice shown in (A) as indicated. |
| T7888 |
1650-1651 |
-LRB- |
denotes |
( |
| T7889 |
1651-1652 |
LS |
denotes |
B |
| T7891 |
1652-1653 |
-RRB- |
denotes |
) |
| T7892 |
1654-1659 |
EX |
denotes |
There |
| T7890 |
1660-1663 |
VBP |
denotes |
are |
| T7893 |
1664-1675 |
JJ |
denotes |
significant |
| T7894 |
1676-1686 |
NNS |
denotes |
elevations |
| T7895 |
1687-1689 |
IN |
denotes |
in |
| T7896 |
1690-1694 |
NN |
denotes |
bile |
| T7897 |
1695-1709 |
NNS |
denotes |
acylcarnitines |
| T7898 |
1710-1712 |
IN |
denotes |
of |
| T7899 |
1713-1716 |
DT |
denotes |
the |
| T7901 |
1717-1721 |
JJ |
denotes |
same |
| T7900 |
1722-1726 |
NNS |
denotes |
mice |
| T7902 |
1727-1732 |
VBN |
denotes |
shown |
| T7903 |
1733-1735 |
IN |
denotes |
in |
| T7904 |
1736-1737 |
-LRB- |
denotes |
( |
| T7905 |
1737-1738 |
NN |
denotes |
A |
| T7906 |
1738-1739 |
-RRB- |
denotes |
) |
| T7907 |
1740-1742 |
IN |
denotes |
as |
| T7908 |
1743-1752 |
VBN |
denotes |
indicated |
| T7909 |
1752-1753 |
. |
denotes |
. |
| T7910 |
1753-1788 |
sentence |
denotes |
Values shown are mean values ± SD. |
| T7911 |
1754-1760 |
NNS |
denotes |
Values |
| T7913 |
1761-1766 |
VBN |
denotes |
shown |
| T7912 |
1767-1770 |
VBP |
denotes |
are |
| T7914 |
1771-1775 |
NN |
denotes |
mean |
| T7915 |
1776-1782 |
NNS |
denotes |
values |
| T7916 |
1783-1784 |
SYM |
denotes |
± |
| T7917 |
1785-1787 |
NN |
denotes |
SD |
| T7918 |
1787-1788 |
. |
denotes |
. |
| T7919 |
1788-1818 |
sentence |
denotes |
Asterisk indicates p < 0.001. |
| T7920 |
1789-1797 |
NN |
denotes |
Asterisk |
| T7921 |
1798-1807 |
VBZ |
denotes |
indicates |
| T7922 |
1808-1809 |
NN |
denotes |
p |
| T7923 |
1810-1811 |
SYM |
denotes |
< |
| T7924 |
1812-1817 |
CD |
denotes |
0.001 |
| T7925 |
1817-1818 |
. |
denotes |
. |
| T7926 |
1818-1919 |
sentence |
denotes |
(C) Bile acylcarnitine profile of an MCAD−/− mouse compared to a human patient with MCAD deficiency. |
| T7927 |
1819-1820 |
-LRB- |
denotes |
( |
| T7928 |
1820-1821 |
LS |
denotes |
C |
| T7930 |
1821-1822 |
-RRB- |
denotes |
) |
| T7931 |
1823-1827 |
NN |
denotes |
Bile |
| T7932 |
1828-1841 |
NN |
denotes |
acylcarnitine |
| T7929 |
1842-1849 |
NN |
denotes |
profile |
| T7933 |
1850-1852 |
IN |
denotes |
of |
| T7934 |
1853-1855 |
DT |
denotes |
an |
| T7936 |
1856-1860 |
NN |
denotes |
MCAD |
| T7937 |
1860-1861 |
SYM |
denotes |
− |
| T7938 |
1861-1862 |
HYPH |
denotes |
/ |
| T7939 |
1862-1863 |
SYM |
denotes |
− |
| T7935 |
1864-1869 |
NN |
denotes |
mouse |
| T7940 |
1870-1878 |
VBN |
denotes |
compared |
| T7941 |
1879-1881 |
IN |
denotes |
to |
| T7942 |
1882-1883 |
DT |
denotes |
a |
| T7944 |
1884-1889 |
JJ |
denotes |
human |
| T7943 |
1890-1897 |
NN |
denotes |
patient |
| T7945 |
1898-1902 |
IN |
denotes |
with |
| T7946 |
1903-1907 |
NN |
denotes |
MCAD |
| T7947 |
1908-1918 |
NN |
denotes |
deficiency |
| T7948 |
1918-1919 |
. |
denotes |
. |
| T7949 |
1919-1968 |
sentence |
denotes |
Internal standards are indicated by an asterisk. |
| T7950 |
1920-1928 |
JJ |
denotes |
Internal |
| T7951 |
1929-1938 |
NNS |
denotes |
standards |
| T7953 |
1939-1942 |
VBP |
denotes |
are |
| T7952 |
1943-1952 |
VBN |
denotes |
indicated |
| T7954 |
1953-1955 |
IN |
denotes |
by |
| T7955 |
1956-1958 |
DT |
denotes |
an |
| T7956 |
1959-1967 |
NN |
denotes |
asterisk |
| T7957 |
1967-1968 |
. |
denotes |
. |
| R1812 |
T2908 |
T2909 |
amod |
Organic,Acid |
| R1813 |
T2910 |
T2909 |
cc |
and,Acid |
| R1814 |
T2911 |
T2912 |
compound |
Acylcarnitine,Analysis |
| R1815 |
T2912 |
T2909 |
conj |
Analysis,Acid |
| R1816 |
T2914 |
T2915 |
nmod |
Urine,acid |
| R1817 |
T2915 |
T2917 |
compound |
acid,analysis |
| R1818 |
T2916 |
T2915 |
amod |
organic,acid |
| R1819 |
T2917 |
T2918 |
nsubj |
analysis,revealed |
| R1820 |
T2919 |
T2920 |
mark |
that,developed |
| R1821 |
T2920 |
T2918 |
ccomp |
developed,revealed |
| R1822 |
T2921 |
T2922 |
nmod |
MCAD,mice |
| R1823 |
T2922 |
T2920 |
nsubj |
mice,developed |
| R1824 |
T2923 |
T2921 |
punct |
−,MCAD |
| R1825 |
T2924 |
T2921 |
punct |
/,MCAD |
| R1826 |
T2925 |
T2921 |
punct |
−,MCAD |
| R1827 |
T2926 |
T2927 |
det |
an,profile |
| R1828 |
T2927 |
T2920 |
dobj |
profile,developed |
| R1829 |
T2928 |
T2929 |
amod |
organic,acid |
| R1830 |
T2929 |
T2927 |
compound |
acid,profile |
| R1831 |
T2930 |
T2927 |
amod |
similar,profile |
| R1832 |
T2931 |
T2930 |
prep |
to,similar |
| R1833 |
T2932 |
T2933 |
npadvmod |
MCAD,deficient |
| R1834 |
T2933 |
T2935 |
amod |
deficient,patients |
| R1835 |
T2934 |
T2933 |
punct |
-,deficient |
| R1836 |
T2935 |
T2931 |
pobj |
patients,to |
| R1837 |
T2936 |
T2935 |
amod |
human,patients |
| R1838 |
T2937 |
T2918 |
punct |
.,revealed |
| R1839 |
T2939 |
T2940 |
advmod |
Specifically,developed |
| R1840 |
T2941 |
T2940 |
punct |
", ",developed |
| R1841 |
T2942 |
T2943 |
advmod |
when,fasted |
| R1842 |
T2943 |
T2940 |
advcl |
fasted,developed |
| R1843 |
T2944 |
T2943 |
prep |
for,fasted |
| R1844 |
T2945 |
T2946 |
nummod |
18,h |
| R1845 |
T2946 |
T2944 |
pobj |
h,for |
| R1846 |
T2947 |
T2940 |
punct |
", ",developed |
| R1847 |
T2948 |
T2949 |
nmod |
MCAD,mice |
| R1848 |
T2949 |
T2940 |
nsubj |
mice,developed |
| R1849 |
T2950 |
T2948 |
punct |
−,MCAD |
| R1850 |
T2951 |
T2948 |
punct |
/,MCAD |
| R1851 |
T2952 |
T2948 |
punct |
−,MCAD |
| R1852 |
T2953 |
T2954 |
advmod |
significantly,elevated |
| R1853 |
T2954 |
T2955 |
amod |
elevated,concentrations |
| R1854 |
T2955 |
T2940 |
dobj |
concentrations,developed |
| R1855 |
T2956 |
T2955 |
prep |
of,concentrations |
| R1856 |
T2957 |
T2958 |
amod |
adipic,acids |
| R1857 |
T2958 |
T2956 |
pobj |
acids,of |
| R1858 |
T2959 |
T2957 |
punct |
", ",adipic |
| R1859 |
T2960 |
T2957 |
conj |
suberic,adipic |
| R1860 |
T2961 |
T2960 |
punct |
", ",suberic |
| R1861 |
T2962 |
T2960 |
cc |
and,suberic |
| R1862 |
T2963 |
T2960 |
conj |
sebacic,suberic |
| R1863 |
T2964 |
T2958 |
cc |
and,acids |
| R1864 |
T2965 |
T2958 |
conj |
hexanoylglycine,acids |
| R1865 |
T2966 |
T2967 |
mark |
as,compared |
| R1866 |
T2967 |
T2940 |
advcl |
compared,developed |
| R1867 |
T2968 |
T2967 |
prep |
to,compared |
| R1868 |
T2969 |
T2970 |
nmod |
MCAD,controls |
| R1869 |
T2970 |
T2968 |
pobj |
controls,to |
| R1870 |
T2971 |
T2969 |
punct |
+,MCAD |
| R1871 |
T2972 |
T2969 |
punct |
/,MCAD |
| R1872 |
T2973 |
T2969 |
punct |
+,MCAD |
| R1873 |
T2974 |
T2970 |
punct |
", ",controls |
| R1874 |
T2975 |
T2976 |
dep |
which,showed |
| R1875 |
T2976 |
T2970 |
relcl |
showed,controls |
| R1876 |
T2977 |
T2976 |
dobj |
trace,showed |
| R1877 |
T2978 |
T2977 |
prep |
to,trace |
| R1878 |
T2979 |
T2980 |
det |
no,amounts |
| R1879 |
T2980 |
T2978 |
pobj |
amounts,to |
| R1880 |
T2981 |
T2980 |
amod |
detectable,amounts |
| R1881 |
T2982 |
T2977 |
prep |
of,trace |
| R1882 |
T2983 |
T2984 |
det |
the,acids |
| R1883 |
T2984 |
T2982 |
pobj |
acids,of |
| R1884 |
T2985 |
T2984 |
amod |
same,acids |
| R1885 |
T2986 |
T2984 |
amod |
organic,acids |
| R1886 |
T2987 |
T2988 |
punct |
(,Table |
| R1887 |
T2988 |
T2940 |
parataxis |
Table,developed |
| R1888 |
T2989 |
T2988 |
nummod |
1,Table |
| R1889 |
T2990 |
T2988 |
punct |
),Table |
| R1890 |
T2991 |
T2940 |
punct |
.,developed |
| R1891 |
T2993 |
T2994 |
amod |
Adipic,acid |
| R1892 |
T2994 |
T2995 |
nsubj |
acid,is |
| R1893 |
T2996 |
T2995 |
neg |
not,is |
| R1894 |
T2997 |
T2995 |
acomp |
specific,is |
| R1895 |
T2998 |
T2997 |
prep |
to,specific |
| R1896 |
T2999 |
T3000 |
compound |
MCAD,deficiency |
| R1897 |
T3000 |
T2998 |
pobj |
deficiency,to |
| R1898 |
T3001 |
T2995 |
punct |
.,is |
| R1899 |
T3003 |
T3004 |
nsubj |
We,evaluated |
| R1900 |
T3005 |
T3004 |
advmod |
also,evaluated |
| R1901 |
T3006 |
T3007 |
npadvmod |
β,hydroxybutyric |
| R1902 |
T3007 |
T3009 |
amod |
hydroxybutyric,concentrations |
| R1903 |
T3008 |
T3007 |
punct |
-,hydroxybutyric |
| R1904 |
T3009 |
T3004 |
dobj |
concentrations,evaluated |
| R1905 |
T3010 |
T3007 |
cc |
and,hydroxybutyric |
| R1906 |
T3011 |
T3007 |
conj |
acetoacetic,hydroxybutyric |
| R1907 |
T3012 |
T3004 |
cc |
and,evaluated |
| R1908 |
T3013 |
T3004 |
conj |
found,evaluated |
| R1909 |
T3014 |
T3015 |
det |
no,differences |
| R1910 |
T3015 |
T3013 |
dobj |
differences,found |
| R1911 |
T3016 |
T3015 |
amod |
significant,differences |
| R1912 |
T3017 |
T3015 |
prep |
between,differences |
| R1913 |
T3018 |
T3019 |
compound |
MCAD,genotypes |
| R1914 |
T3019 |
T3017 |
pobj |
genotypes,between |
| R1915 |
T3020 |
T3021 |
punct |
(,shown |
| R1916 |
T3021 |
T3013 |
parataxis |
shown,found |
| R1917 |
T3022 |
T3021 |
nsubj |
data,shown |
| R1918 |
T3023 |
T3021 |
neg |
not,shown |
| R1919 |
T3024 |
T3021 |
punct |
),shown |
| R1920 |
T3025 |
T3004 |
punct |
.,evaluated |
| R1921 |
T3027 |
T3028 |
nsubj |
Comparison,revealed |
| R1922 |
T3029 |
T3027 |
prep |
of,Comparison |
| R1923 |
T3030 |
T3031 |
nmod |
MCAD,mice |
| R1924 |
T3031 |
T3029 |
pobj |
mice,of |
| R1925 |
T3032 |
T3030 |
punct |
+,MCAD |
| R1926 |
T3033 |
T3030 |
punct |
/,MCAD |
| R1927 |
T3034 |
T3030 |
punct |
+,MCAD |
| R1928 |
T3035 |
T3030 |
cc |
and,MCAD |
| R1929 |
T3036 |
T3030 |
conj |
MCAD,MCAD |
| R1930 |
T3037 |
T3036 |
punct |
−,MCAD |
| R1931 |
T3038 |
T3036 |
punct |
/,MCAD |
| R1932 |
T3039 |
T3036 |
punct |
−,MCAD |
| R1933 |
T3040 |
T3041 |
det |
no,differences |
| R1934 |
T3041 |
T3028 |
dobj |
differences,revealed |
| R1935 |
T3042 |
T3041 |
amod |
significant,differences |
| R1936 |
T3043 |
T3041 |
prep |
in,differences |
| R1937 |
T3044 |
T3045 |
amod |
total,concentrations |
| R1938 |
T3045 |
T3043 |
pobj |
concentrations,in |
| R1939 |
T3046 |
T3045 |
compound |
serum,concentrations |
| R1940 |
T3047 |
T3045 |
compound |
carnitine,concentrations |
| R1941 |
T3048 |
T3041 |
prep |
between,differences |
| R1942 |
T3049 |
T3050 |
nmod |
MCAD,mice |
| R1943 |
T3050 |
T3048 |
pobj |
mice,between |
| R1944 |
T3051 |
T3049 |
punct |
+,MCAD |
| R1945 |
T3052 |
T3049 |
punct |
/,MCAD |
| R1946 |
T3053 |
T3049 |
punct |
+,MCAD |
| R1947 |
T3054 |
T3049 |
cc |
and,MCAD |
| R1948 |
T3055 |
T3049 |
conj |
MCAD,MCAD |
| R1949 |
T3056 |
T3055 |
punct |
−,MCAD |
| R1950 |
T3057 |
T3055 |
punct |
/,MCAD |
| R1951 |
T3058 |
T3055 |
punct |
−,MCAD |
| R1952 |
T3059 |
T3028 |
punct |
", ",revealed |
| R1953 |
T3060 |
T3028 |
cc |
but,revealed |
| R1954 |
T3061 |
T3062 |
nmod |
MCAD,mice |
| R1955 |
T3062 |
T3066 |
nsubj |
mice,had |
| R1956 |
T3063 |
T3061 |
punct |
−,MCAD |
| R1957 |
T3064 |
T3061 |
punct |
/,MCAD |
| R1958 |
T3065 |
T3061 |
punct |
−,MCAD |
| R1959 |
T3066 |
T3028 |
conj |
had,revealed |
| R1960 |
T3067 |
T3068 |
det |
a,elevation |
| R1961 |
T3068 |
T3075 |
nsubj |
elevation,evident |
| R1962 |
T3069 |
T3070 |
quantmod |
5,6 |
| R1963 |
T3070 |
T3073 |
quantmod |
6,fold |
| R1964 |
T3071 |
T3070 |
punct |
-,6 |
| R1965 |
T3072 |
T3070 |
quantmod |
to,6 |
| R1966 |
T3073 |
T3068 |
nummod |
fold,elevation |
| R1967 |
T3074 |
T3073 |
punct |
-,fold |
| R1968 |
T3075 |
T3066 |
ccomp |
evident,had |
| R1969 |
T3076 |
T3068 |
prep |
of,elevation |
| R1970 |
T3077 |
T3078 |
compound |
serum,decenoylcarnitine |
| R1971 |
T3078 |
T3076 |
pobj |
decenoylcarnitine,of |
| R1972 |
T3079 |
T3075 |
prep |
in,evident |
| R1973 |
T3080 |
T3081 |
det |
the,profile |
| R1974 |
T3081 |
T3079 |
pobj |
profile,in |
| R1975 |
T3082 |
T3081 |
compound |
acylcarnitine,profile |
| R1976 |
T3083 |
T3084 |
punct |
(,Figure |
| R1977 |
T3084 |
T3066 |
parataxis |
Figure,had |
| R1978 |
T3085 |
T3084 |
nummod |
4A,Figure |
| R1979 |
T3086 |
T3084 |
punct |
),Figure |
| R1980 |
T3087 |
T3066 |
punct |
.,had |
| R1981 |
T3089 |
T3090 |
compound |
Bile,acylcarnitine |
| R1982 |
T3090 |
T3091 |
compound |
acylcarnitine,analysis |
| R1983 |
T3091 |
T3092 |
nsubj |
analysis,revealed |
| R1984 |
T3093 |
T3094 |
det |
a,pattern |
| R1985 |
T3094 |
T3092 |
dobj |
pattern,revealed |
| R1986 |
T3095 |
T3094 |
amod |
similar,pattern |
| R1987 |
T3096 |
T3094 |
compound |
acylcarnitine,pattern |
| R1988 |
T3097 |
T3094 |
prep |
as,pattern |
| R1989 |
T3098 |
T3097 |
prep |
in,as |
| R1990 |
T3099 |
T3098 |
pobj |
serum,in |
| R1991 |
T3100 |
T3101 |
punct |
(,Figure |
| R1992 |
T3101 |
T3092 |
parataxis |
Figure,revealed |
| R1993 |
T3102 |
T3101 |
nummod |
4B,Figure |
| R1994 |
T3103 |
T3101 |
punct |
),Figure |
| R1995 |
T3104 |
T3092 |
punct |
.,revealed |
| R1996 |
T3106 |
T3107 |
advmod |
However,are |
| R1997 |
T3108 |
T3107 |
punct |
", ",are |
| R1998 |
T3109 |
T3110 |
det |
the,profiles |
| R1999 |
T3110 |
T3107 |
nsubj |
profiles,are |
| R2000 |
T3111 |
T3110 |
compound |
acylcarnitine,profiles |
| R2001 |
T3112 |
T3110 |
prep |
of,profiles |
| R2002 |
T3113 |
T3114 |
det |
the,mice |
| R2003 |
T3114 |
T3112 |
pobj |
mice,of |
| R2004 |
T3115 |
T3114 |
nmod |
MCAD,mice |
| R2005 |
T3116 |
T3115 |
punct |
−,MCAD |
| R2006 |
T3117 |
T3115 |
punct |
/,MCAD |
| R2007 |
T3118 |
T3115 |
punct |
−,MCAD |
| R2008 |
T3119 |
T3107 |
acomp |
different,are |
| R2009 |
T3120 |
T3119 |
prep |
from,different |
| R2010 |
T3121 |
T3120 |
pobj |
those,from |
| R2011 |
T3122 |
T3121 |
prep |
of,those |
| R2012 |
T3123 |
T3124 |
amod |
human,patients |
| R2013 |
T3124 |
T3122 |
pobj |
patients,of |
| R2014 |
T3125 |
T3126 |
npadvmod |
MCAD,deficient |
| R2015 |
T3126 |
T3124 |
amod |
deficient,patients |
| R2016 |
T3127 |
T3126 |
punct |
-,deficient |
| R2017 |
T3128 |
T3129 |
punct |
(,Figure |
| R2018 |
T3129 |
T3107 |
parataxis |
Figure,are |
| R2019 |
T3130 |
T3129 |
nummod |
4C,Figure |
| R2020 |
T3131 |
T3129 |
punct |
),Figure |
| R2021 |
T3132 |
T3107 |
punct |
.,are |
| R2022 |
T3134 |
T3135 |
amod |
Human,patients |
| R2023 |
T3135 |
T3136 |
nsubj |
patients,present |
| R2024 |
T3136 |
T3137 |
ccomp |
present,was |
| R2025 |
T3138 |
T3136 |
prep |
with,present |
| R2026 |
T3139 |
T3140 |
amod |
elevated,levels |
| R2027 |
T3140 |
T3138 |
pobj |
levels,with |
| R2028 |
T3141 |
T3140 |
prep |
of,levels |
| R2029 |
T3142 |
T3141 |
pobj |
C6,of |
| R2030 |
T3143 |
T3142 |
punct |
", ",C6 |
| R2031 |
T3144 |
T3142 |
conj |
C8,C6 |
| R2032 |
T3145 |
T3144 |
punct |
", ",C8 |
| R2033 |
T3146 |
T3144 |
cc |
and,C8 |
| R2034 |
T3147 |
T3144 |
conj |
C10,C8 |
| R2035 |
T3148 |
T3147 |
punct |
:,C10 |
| R2036 |
T3149 |
T3147 |
nummod |
1,C10 |
| R2037 |
T3150 |
T3142 |
appos |
acylcarnitines,C6 |
| R2038 |
T3151 |
T3136 |
punct |
", ",present |
| R2039 |
T3152 |
T3153 |
mark |
as,did |
| R2040 |
T3153 |
T3136 |
advcl |
did,present |
| R2041 |
T3154 |
T3155 |
det |
the,mice |
| R2042 |
T3155 |
T3153 |
nsubj |
mice,did |
| R2043 |
T3156 |
T3155 |
compound |
mutant,mice |
| R2044 |
T3157 |
T3137 |
punct |
;,was |
| R2045 |
T3158 |
T3137 |
advmod |
however,was |
| R2046 |
T3159 |
T3137 |
punct |
", ",was |
| R2047 |
T3160 |
T3161 |
det |
the,peak |
| R2048 |
T3161 |
T3137 |
nsubj |
peak,was |
| R2049 |
T3162 |
T3161 |
amod |
predominant,peak |
| R2050 |
T3163 |
T3164 |
compound |
C8,acylcarnitine |
| R2051 |
T3164 |
T3137 |
attr |
acylcarnitine,was |
| R2052 |
T3165 |
T3137 |
prep |
in,was |
| R2053 |
T3166 |
T3165 |
pobj |
humans,in |
| R2054 |
T3167 |
T3137 |
punct |
", ",was |
| R2055 |
T3168 |
T3169 |
mark |
whereas,was |
| R2056 |
T3169 |
T3137 |
advcl |
was,was |
| R2057 |
T3170 |
T3169 |
prep |
in,was |
| R2058 |
T3171 |
T3172 |
det |
the,mouse |
| R2059 |
T3172 |
T3170 |
pobj |
mouse,in |
| R2060 |
T3173 |
T3169 |
nsubj |
it,was |
| R2061 |
T3174 |
T3175 |
nmod |
C10,acylcarnitine |
| R2062 |
T3175 |
T3169 |
attr |
acylcarnitine,was |
| R2063 |
T3176 |
T3174 |
punct |
:,C10 |
| R2064 |
T3177 |
T3174 |
nummod |
1,C10 |
| R2065 |
T3178 |
T3137 |
punct |
.,was |
| R5004 |
T7814 |
T7815 |
compound |
Acylcarnitine,Analyses |
| R5005 |
T7817 |
T7818 |
punct |
(,A |
| R5006 |
T7818 |
T7819 |
meta |
A,analysis |
| R5007 |
T7820 |
T7818 |
punct |
),A |
| R5008 |
T7821 |
T7822 |
compound |
Serum,acylcarnitine |
| R5009 |
T7822 |
T7819 |
compound |
acylcarnitine,analysis |
| R5010 |
T7823 |
T7819 |
prep |
of,analysis |
| R5011 |
T7824 |
T7825 |
nmod |
MCAD,mice |
| R5012 |
T7825 |
T7823 |
pobj |
mice,of |
| R5013 |
T7826 |
T7824 |
punct |
+,MCAD |
| R5014 |
T7827 |
T7824 |
punct |
/,MCAD |
| R5015 |
T7828 |
T7824 |
punct |
+,MCAD |
| R5016 |
T7829 |
T7830 |
punct |
(,4 |
| R5017 |
T7830 |
T7824 |
parataxis |
4,MCAD |
| R5018 |
T7831 |
T7830 |
nsubj |
n,4 |
| R5019 |
T7832 |
T7830 |
punct |
=,4 |
| R5020 |
T7833 |
T7830 |
punct |
),4 |
| R5021 |
T7834 |
T7824 |
cc |
and,MCAD |
| R5022 |
T7835 |
T7824 |
conj |
MCAD,MCAD |
| R5023 |
T7836 |
T7835 |
punct |
−,MCAD |
| R5024 |
T7837 |
T7835 |
punct |
/,MCAD |
| R5025 |
T7838 |
T7835 |
punct |
−,MCAD |
| R5026 |
T7839 |
T7840 |
punct |
(,4 |
| R5027 |
T7840 |
T7825 |
parataxis |
4,mice |
| R5028 |
T7841 |
T7840 |
nsubj |
n,4 |
| R5029 |
T7842 |
T7840 |
punct |
=,4 |
| R5030 |
T7843 |
T7840 |
punct |
),4 |
| R5031 |
T7845 |
T7846 |
expl |
There,are |
| R5032 |
T7847 |
T7848 |
amod |
significant,elevations |
| R5033 |
T7848 |
T7846 |
attr |
elevations,are |
| R5034 |
T7849 |
T7846 |
prep |
in,are |
| R5035 |
T7850 |
T7851 |
compound |
acylcarnitine,species |
| R5036 |
T7851 |
T7849 |
pobj |
species,in |
| R5037 |
T7852 |
T7853 |
mark |
as,indicated |
| R5038 |
T7853 |
T7846 |
advcl |
indicated,are |
| R5039 |
T7854 |
T7853 |
prep |
in,indicated |
| R5040 |
T7855 |
T7856 |
nmod |
MCAD,mice |
| R5041 |
T7856 |
T7854 |
pobj |
mice,in |
| R5042 |
T7857 |
T7855 |
punct |
−,MCAD |
| R5043 |
T7858 |
T7855 |
punct |
/,MCAD |
| R5044 |
T7859 |
T7855 |
punct |
−,MCAD |
| R5045 |
T7860 |
T7846 |
punct |
.,are |
| R5046 |
T7862 |
T7863 |
nsubj |
Values,are |
| R5047 |
T7864 |
T7862 |
acl |
shown,Values |
| R5048 |
T7865 |
T7866 |
compound |
mean,values |
| R5049 |
T7866 |
T7863 |
attr |
values,are |
| R5050 |
T7867 |
T7866 |
punct |
±,values |
| R5051 |
T7868 |
T7869 |
amod |
standard,deviation |
| R5052 |
T7869 |
T7866 |
appos |
deviation,values |
| R5053 |
T7870 |
T7869 |
punct |
(,deviation |
| R5054 |
T7871 |
T7869 |
appos |
SD,deviation |
| R5055 |
T7872 |
T7863 |
punct |
),are |
| R5056 |
T7873 |
T7863 |
punct |
.,are |
| R5057 |
T7875 |
T7876 |
nsubj |
Asterisk,indicates |
| R5058 |
T7877 |
T7876 |
dobj |
p,indicates |
| R5059 |
T7878 |
T7879 |
punct |
<,0.002 |
| R5060 |
T7879 |
T7877 |
amod |
0.002,p |
| R5061 |
T7880 |
T7876 |
cc |
and,indicates |
| R5062 |
T7881 |
T7882 |
nsubj |
‡,indicates |
| R5063 |
T7882 |
T7876 |
conj |
indicates,indicates |
| R5064 |
T7883 |
T7882 |
dobj |
p,indicates |
| R5065 |
T7884 |
T7885 |
punct |
<,0.01 |
| R5066 |
T7885 |
T7883 |
amod |
0.01,p |
| R5067 |
T7886 |
T7882 |
punct |
.,indicates |
| R5068 |
T7888 |
T7889 |
punct |
(,B |
| R5069 |
T7889 |
T7890 |
meta |
B,are |
| R5070 |
T7891 |
T7889 |
punct |
),B |
| R5071 |
T7892 |
T7890 |
expl |
There,are |
| R5072 |
T7893 |
T7894 |
amod |
significant,elevations |
| R5073 |
T7894 |
T7890 |
attr |
elevations,are |
| R5074 |
T7895 |
T7894 |
prep |
in,elevations |
| R5075 |
T7896 |
T7897 |
compound |
bile,acylcarnitines |
| R5076 |
T7897 |
T7895 |
pobj |
acylcarnitines,in |
| R5077 |
T7898 |
T7897 |
prep |
of,acylcarnitines |
| R5078 |
T7899 |
T7900 |
det |
the,mice |
| R5079 |
T7900 |
T7898 |
pobj |
mice,of |
| R5080 |
T7901 |
T7900 |
amod |
same,mice |
| R5081 |
T7902 |
T7900 |
acl |
shown,mice |
| R5082 |
T7903 |
T7902 |
prep |
in,shown |
| R5083 |
T7904 |
T7903 |
punct |
(,in |
| R5084 |
T7905 |
T7903 |
pobj |
A,in |
| R5085 |
T7906 |
T7902 |
punct |
),shown |
| R5086 |
T7907 |
T7908 |
mark |
as,indicated |
| R5087 |
T7908 |
T7902 |
advcl |
indicated,shown |
| R5088 |
T7909 |
T7890 |
punct |
.,are |
| R5089 |
T7911 |
T7912 |
nsubj |
Values,are |
| R5090 |
T7913 |
T7911 |
acl |
shown,Values |
| R5091 |
T7914 |
T7915 |
compound |
mean,values |
| R5092 |
T7915 |
T7912 |
attr |
values,are |
| R5093 |
T7916 |
T7915 |
punct |
±,values |
| R5094 |
T7917 |
T7915 |
appos |
SD,values |
| R5095 |
T7918 |
T7912 |
punct |
.,are |
| R5096 |
T7920 |
T7921 |
nsubj |
Asterisk,indicates |
| R5097 |
T7922 |
T7921 |
dobj |
p,indicates |
| R5098 |
T7923 |
T7924 |
punct |
<,0.001 |
| R5099 |
T7924 |
T7922 |
amod |
0.001,p |
| R5100 |
T7925 |
T7921 |
punct |
.,indicates |
| R5101 |
T7927 |
T7928 |
punct |
(,C |
| R5102 |
T7928 |
T7929 |
meta |
C,profile |
| R5103 |
T7930 |
T7928 |
punct |
),C |
| R5104 |
T7931 |
T7932 |
compound |
Bile,acylcarnitine |
| R5105 |
T7932 |
T7929 |
compound |
acylcarnitine,profile |
| R5106 |
T7933 |
T7929 |
prep |
of,profile |
| R5107 |
T7934 |
T7935 |
det |
an,mouse |
| R5108 |
T7935 |
T7933 |
pobj |
mouse,of |
| R5109 |
T7936 |
T7935 |
nmod |
MCAD,mouse |
| R5110 |
T7937 |
T7936 |
punct |
−,MCAD |
| R5111 |
T7938 |
T7936 |
punct |
/,MCAD |
| R5112 |
T7939 |
T7936 |
punct |
−,MCAD |
| R5113 |
T7940 |
T7929 |
prep |
compared,profile |
| R5114 |
T7941 |
T7940 |
prep |
to,compared |
| R5115 |
T7942 |
T7943 |
det |
a,patient |
| R5116 |
T7943 |
T7941 |
pobj |
patient,to |
| R5117 |
T7944 |
T7943 |
amod |
human,patient |
| R5118 |
T7945 |
T7943 |
prep |
with,patient |
| R5119 |
T7946 |
T7947 |
compound |
MCAD,deficiency |
| R5120 |
T7947 |
T7945 |
pobj |
deficiency,with |
| R5121 |
T7948 |
T7929 |
punct |
.,profile |
| R5122 |
T7950 |
T7951 |
amod |
Internal,standards |
| R5123 |
T7951 |
T7952 |
nsubjpass |
standards,indicated |
| R5124 |
T7953 |
T7952 |
auxpass |
are,indicated |
| R5125 |
T7954 |
T7952 |
prep |
by,indicated |
| R5126 |
T7955 |
T7956 |
det |
an,asterisk |
| R5127 |
T7956 |
T7954 |
pobj |
asterisk,by |
| R5128 |
T7957 |
T7952 |
punct |
.,indicated |
